EP1212073A4 - Method for measuring coagulant factor activity in whole blood - Google Patents

Method for measuring coagulant factor activity in whole blood

Info

Publication number
EP1212073A4
EP1212073A4 EP00950617A EP00950617A EP1212073A4 EP 1212073 A4 EP1212073 A4 EP 1212073A4 EP 00950617 A EP00950617 A EP 00950617A EP 00950617 A EP00950617 A EP 00950617A EP 1212073 A4 EP1212073 A4 EP 1212073A4
Authority
EP
European Patent Office
Prior art keywords
whole blood
factor activity
coagulant factor
measuring
measuring coagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00950617A
Other languages
German (de)
French (fr)
Other versions
EP1212073A1 (en
Inventor
Nigel Mackman
John J Mcdonnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of EP1212073A1 publication Critical patent/EP1212073A1/en
Publication of EP1212073A4 publication Critical patent/EP1212073A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00950617A 1999-07-23 2000-07-24 Method for measuring coagulant factor activity in whole blood Withdrawn EP1212073A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14514099P 1999-07-23 1999-07-23
US145140P 1999-07-23
PCT/US2000/020118 WO2001007070A1 (en) 1999-07-23 2000-07-24 Method for measuring coagulant factor activity in whole blood

Publications (2)

Publication Number Publication Date
EP1212073A1 EP1212073A1 (en) 2002-06-12
EP1212073A4 true EP1212073A4 (en) 2003-09-03

Family

ID=22511767

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00950617A Withdrawn EP1212073A4 (en) 1999-07-23 2000-07-24 Method for measuring coagulant factor activity in whole blood

Country Status (7)

Country Link
EP (1) EP1212073A4 (en)
JP (1) JP2003505678A (en)
KR (1) KR20020042622A (en)
CN (1) CN1368886A (en)
AU (1) AU6369700A (en)
CA (1) CA2378898A1 (en)
WO (1) WO2001007070A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
DE102005005824A1 (en) * 2005-02-08 2006-08-17 Zlb Behring Gmbh Method for differentiating factor XIII versus fibrinogen-deficient states using thrombelastographic techniques
JP4267592B2 (en) 2005-05-23 2009-05-27 潤 川崎 Antithrombotic drug efficacy test method
CN100434901C (en) * 2006-01-12 2008-11-19 上海交通大学 Teaching kit for hemoglobin gel chromatography
US20090004673A1 (en) * 2006-01-31 2009-01-01 Mitsubishi Kagaku Iatron, Inc. Method for Determining Condition of Disseminated Intravascular Coagulation
GB0701821D0 (en) * 2007-02-01 2007-03-14 Pentapharm Ag Diagnostic composition and its use in the determination of coagulation characteristics of a test liquid
WO2009046274A1 (en) * 2007-10-03 2009-04-09 The University Of Vermont And State Agriculture College Methods of detection of factor xia and tissue factor
US8450275B2 (en) 2010-03-19 2013-05-28 Baxter International Inc. TFPI inhibitors and methods of use
KR101792032B1 (en) 2008-12-19 2017-11-02 백스터 인터내셔널 인코포레이티드 Tfpi inhibitors and methods of use
EP2471945A1 (en) * 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Method for determining coagulation inhibitors
LT2827883T (en) 2012-03-21 2019-08-12 Baxalta GmbH Tfpi inhibitors and methods of use
RU2682622C2 (en) * 2012-10-25 2019-03-19 Конинклейке Филипс Н.В. Combined use of clinical risk factors and molecular markers of thrombosis for clinical decision support
LT2946206T (en) 2013-01-20 2019-04-25 Dyax Corp. Evaluation, assays and treatment of pkal-mediated disorders
EP2818871A1 (en) 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests
CN103604766A (en) * 2013-11-25 2014-02-26 牡丹江友搏药业股份有限公司 Biological quality control method of Shuxuetong injection
US9452199B2 (en) 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses
SE540132C2 (en) * 2014-05-22 2018-04-10 Zafena Ab Method of analysis for the determination of anticoagulants in blood or blood plasma
CN104345154B (en) * 2014-08-22 2016-10-26 北京蛋白质组研究中心 A kind of double-antibody sandwich test kit detecting many tumors relevant " the box-like mark of polypeptide-protein groups "
CN104177503B (en) * 2014-08-22 2018-04-13 北京蛋白质组研究中心 A kind of related " polypeptide protein combined type " marker of kinase pathway and quantitative measurement technology
CN104698159B (en) * 2015-03-10 2017-03-08 中国科学院苏州生物医学工程技术研究所 A kind of detection method of endotoxin content
WO2018128002A1 (en) * 2017-01-06 2018-07-12 ソニー株式会社 Blood-coagulation-system analyzer, blood-coagulation-system analysis system, blood-coagulation-system analysis method, blood-coagulation-system analysis program, hemorrhage-volume predictor, hemorrhage-volume prediction system, hemorrhage-volume prediction method, and hemorrhage-volume prediction program
US20210263052A1 (en) * 2018-07-25 2021-08-26 Sony Corporation Blood coagulation system analysis device
CN113906295A (en) * 2019-03-15 2022-01-07 考爱古莱森科技有限责任公司 Coagulation test devices, systems, and methods of use
US10429377B1 (en) 2019-03-15 2019-10-01 Coagulation Sciences Llc Coagulation test device, system, and method of use
CN114402200A (en) 2019-04-16 2022-04-26 武田药品工业株式会社 Method for quantifying functional C1 esterase inhibitor (FC1-INH)
RU2750839C1 (en) * 2020-05-18 2021-07-05 Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Т") Apparatus and method for express estimation of aggregative activity of formed elements of blood
WO2022145475A1 (en) * 2020-12-28 2022-07-07 藤森工業株式会社 Method for evaluating blood coagulation performance, and method for inspecting risk of thrombosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814247A (en) * 1983-01-26 1989-03-21 University Of Medicine And Dentistry Of New Jersey Method for determining the existance and/or the monitoring of a pathological condition in a mammal
WO1999064622A1 (en) * 1998-06-08 1999-12-16 University Of Vermont And State Agriculture College Inhibition of coagulation in blood and blood products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882272A (en) * 1986-10-01 1989-11-21 Temple University - Of The Commonwealth System Of Higher Education High molecular weight kininogen assay
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
US5783447A (en) * 1996-10-02 1998-07-21 University Of Medicine And Dentistry Of New Jersey Hypercoagulability comparative determinants obtained using detection systems with variable force-induced energy inputs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814247A (en) * 1983-01-26 1989-03-21 University Of Medicine And Dentistry Of New Jersey Method for determining the existance and/or the monitoring of a pathological condition in a mammal
WO1999064622A1 (en) * 1998-06-08 1999-12-16 University Of Vermont And State Agriculture College Inhibition of coagulation in blood and blood products

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ERLICH JONATHAN H ET AL: "Measurement of tissue factor activity in whole blood.", BLOOD, vol. 94, no. 10 SUPPL. 1 PART 2, 15 November 1999 (1999-11-15), Forty-first Annual Meeting of the American Society of Hematology;New Orleans, Louisiana, USA; December 3-7, 1999, pages 87b, XP009010631, ISSN: 0006-4971 *
OSTERUD B ET AL: "THE PRODUCTION AND AVAILABILITY OF TISSUE THROMBOPLASTIN IN CELLULAR POPULATIONS OF WHOLE BLOOD EXPOSED TO VARIOUS CONCENTRATIONS OF ENDO TOXIN AN ASSAY FOR DETECTION OF ENDO TOXIN", SCANDINAVIAN JOURNAL OF HAEMATOLOGY, vol. 29, no. 2, 1982, pages 175 - 184, XP009010612, ISSN: 0036-553X *
SANTUCCI R A ET AL: "MEASUREMENT OF TISSUE FACTOR ACTIVITY IN WHOLE BLOOD", THROMBOSIS AND HAEMOSTASIS, STUTTGART, DE, vol. 83, no. 3, March 2000 (2000-03-01), pages 445 - 454, XP009010630, ISSN: 0340-6245 *
See also references of WO0107070A1 *

Also Published As

Publication number Publication date
WO2001007070A1 (en) 2001-02-01
KR20020042622A (en) 2002-06-05
AU6369700A (en) 2001-02-13
CA2378898A1 (en) 2001-02-01
CN1368886A (en) 2002-09-11
JP2003505678A (en) 2003-02-12
EP1212073A1 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
EP1212073A4 (en) Method for measuring coagulant factor activity in whole blood
IL144401A0 (en) System and method for noninvasive blood analyte measurements
EP1229826A4 (en) Method and apparatus for determining cardiac output
IL145942A0 (en) Method and apparatus for measuring cardiac flow output
HK1035651A1 (en) Method and arrangement for heartbeat detection
HK1043833A1 (en) System and method for accurately determining remaining battery life
AU7466500A (en) Method and apparatus for detecting blood characteristics including hemoglobin
HK1048932A1 (en) Body fat measurement method and device therefor
EP1242798A4 (en) Whole blood collection device and method
EP1184665A4 (en) Method for measuring protein kinase activity
IL134123A (en) Method and system for measuring heart rate variability
GB2355385B (en) Breast measuring method and apparatus
IL150167A0 (en) Method for in vivo sensing
AU2003267225A8 (en) System and method for monitoring changes in body position
GB2358706B (en) Method for evaluating skin health
EP1172655A4 (en) A method for detecting megsin protein and use thereof
EP0877922A4 (en) Method for monitoring biological activity in fluids
HUP0202444A3 (en) Method and kit for immuno-detecting bacteria in blood and tissues
GB2360430B (en) Convergence measuring apparatus and method
GB2345972B (en) Method for detecting flow-reducing changes in an exhaust-gas catalyst body
GB0023599D0 (en) Non-invasive method for determining human photodermatoogical skin-types
EP1210451A4 (en) Rapid method for measuring complex carbohydrates in mammalian tissue
GB9929720D0 (en) Diagnostic method
AU5681400A (en) Method and device for measuring blood fractions and clinical parameters in a non-invasive manner
GB2389664B (en) Method for evaluating skin health

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020225

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

R17P Request for examination filed (corrected)

Effective date: 20020225

A4 Supplementary search report drawn up and despatched

Effective date: 20030722

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031118